0001808805-22-000072.txt : 20220616
0001808805-22-000072.hdr.sgml : 20220616
20220616200448
ACCESSION NUMBER: 0001808805-22-000072
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220615
FILED AS OF DATE: 20220616
DATE AS OF CHANGE: 20220616
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McIlwain Matthew S
CENTRAL INDEX KEY: 0001381752
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39434
FILM NUMBER: 221022041
MAIL ADDRESS:
STREET 1: 1000 SECOND AVENUE
STREET 2: SUITE 3700
CITY: SEATTLE
STATE: WA
ZIP: 98104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nautilus Biotechnology, Inc.
CENTRAL INDEX KEY: 0001808805
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2701 EASTLAKE AVE EAST
CITY: SEATTLE
STATE: WA
ZIP: 98102
BUSINESS PHONE: 206-333-2001
MAIL ADDRESS:
STREET 1: 2701 EASTLAKE AVE EAST
CITY: SEATTLE
STATE: WA
ZIP: 98102
FORMER COMPANY:
FORMER CONFORMED NAME: ARYA Sciences Acquisition Corp III
DATE OF NAME CHANGE: 20200408
4
1
wf-form4_165542426104251.xml
FORM 4
X0306
4
2022-06-15
0
0001808805
Nautilus Biotechnology, Inc.
NAUT
0001381752
McIlwain Matthew S
C/O NAUTILUS BIOTECHNOLOGY, INC.
2701 EASTLAKE AVE. E.
SEATTLE
WA
98102
1
0
0
0
Stock Option (Right to Buy)
2.7
2022-06-15
4
A
0
86467
0
A
2032-06-15
Common Stock
86467.0
86467
D
Subject to reporting person's continuous status as a "Service Provider" (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable vesting date, one-twelfth (1/12th) of the shares subject to the Option shall vest on a monthly basis following the date of grant on the same day of the month as such grant date (or on the last day of the month, if there is no corresponding day in such month).
/s/ Matthew B. Murphy, as Attorney-in-Fact
2022-06-16